Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3764612017 | Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| 3764613010 | Amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Is a | Product containing pancreatic enzyme (product) | true | Inferred relationship | Some | ||
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Oral capsule | true | Inferred relationship | Some | ||
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Endopeptidase | true | Inferred relationship | Some | 1 | |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | Unit | true | Inferred relationship | Some | 1 | |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Endopeptidase | true | Inferred relationship | Some | 1 | |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Pancreatic lipase | true | Inferred relationship | Some | 2 | |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | Unit | true | Inferred relationship | Some | 2 | |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Pancreatic lipase | true | Inferred relationship | Some | 2 | |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Amylase (substance) | true | Inferred relationship | Some | 3 | |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | Unit | true | Inferred relationship | Some | 3 | |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 3 | |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Amylase (substance) | true | Inferred relationship | Some | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR